Clinical trial
Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma
NCT00002535 · St. Luke's Medical Center, Other · Completed
Key facts
| NCT number | NCT00002535 |
|---|---|
| Title | Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma |
| Official title | TUMOR INFILTRATING LYMPHOCYTE THERAPY FOR ADVANCED MELANOMA USING IMMUNOMODULATION, A PHASE II STUDY |
| Lead sponsor | St. Luke's Medical Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Biological, Drug |
| Interventions | aldesleukin, lymphokine-activated killer cells, therapeutic tumor infiltrating lymphocytes, cyclophosphamide, indomethacin |
| Start date | Jul 1, 1993 |
| Completion | Jul 1, 2004 |
| First posted | Jul 29, 2004 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: